Market Place
Sourcing Support
Prestige`s Tuznue (trastuzumab) Receives Approval in Europe
19 Sep 2024 //
EMA
Prestige Biopharma`s Tuznue® Receives Positive CHMP Opinion
31 Jul 2024 //
PR NEWSWIRE
Prestige Receives FDA Fast Track Designation for PBP1510
21 Mar 2023 //
BUSINESSWIRE
Prestige Biopharma Develops First-in-Class PAUF-detecting Diagnostic Kit
09 Mar 2023 //
BUSINESSWIRE
Prestige Submitted Pre-BLA Meeting Request to FDA for Herceptin Biosimilar
13 Oct 2022 //
BUSINESSWIRE
Prestige Biopharma and Intas Partner to Commercialize Bevacizumab Biosimilar
26 Jul 2022 //
BUSINESSWIRE
Prestige Biopharma receives FDA approval for Phase I/IIa pancreatic cancer trial
30 Jun 2022 //
CLINICALTRIALSARENA
US FDA Approves Prestige Biopharma’s IND for PI/IIa Trial of PBP1510
27 Jun 2022 //
BUSINESSWIRE
‘EMA’s refusal to authorize Herceptin biosimilar unfair’
23 May 2022 //
KOREABIOMED
Prestige Bio Enters MOU with Vaxine for Supply of COVID-19 and Combo Vaccine
29 Mar 2022 //
BUSINESSWIRE
Result of Phase 3 Study for Prestige’s HD201 Published in JAMA Oncology
11 Mar 2022 //
BUSINESSWIRE
Preclinical Data of Prestige Biopharma’s PBP1510 Presented in ESMO TAT 2022
07 Mar 2022 //
BUSINESSWIRE
Prestige BioPharma’s Herceptin Biosimilar, Tuznue, Receives EU-GMP Certification
21 Feb 2022 //
BUSINESSWIRE
Prestige BioPharma Commences Construction of IDC in Busan, Korea
19 Dec 2021 //
BIOSPACE
Dr Reddy`s Laboratories, Prestige BioPharma to commercialize Trastuzumab
09 Dec 2021 //
BUSINESS-STANDARD
Prestige, Dr. Reddy’s partner to commercialize trastuzumab biosimilar
08 Dec 2021 //
BUSINESSWIRE
Prestige BioPharma’s Shareholders, Appreciate its High Growth Potential
02 Aug 2021 //
BUSINESS WIRE
Prestige Bio receives French ANSM approval for phase 1/2a trial of PBP1510
22 Jun 2021 //
PHARMABIZ
Prestige Biopharma’s PBP1510, Receives Approval for Clinical Trial in France
21 Jun 2021 //
BUSINESSWIRE
Prestige to acquire Akorn’s consumer product portfolio for $230m
28 May 2021 //
PHARMACEUTICAL-TECHNOLOGY
Prestige Biopharma to open vaccine production centre in South Korea
20 Apr 2021 //
BIOSPECTRUMASIA
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases
20 Apr 2021 //
BUSINESSWIRE
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases
19 Apr 2021 //
BUSINESSWIRE
Prestige Biopharma to open vaccine production centre in South Korea
19 Apr 2021 //
BIOSPECTRUMASIA
Prestige Biopharma and Pharmapark Announce License and Supply Agreement
15 Apr 2021 //
BUSINESSWIRE
Moderna taps Baxter for COVID shot production
08 Mar 2021 //
FIERCEPHARMA
Prestige Biopharma and Teva Israel Announce License and Supply Agreement
10 Nov 2020 //
BIOSPACE
Prestige Receives Positive EMA Opinion on Orphan Designation for PBP1510
19 Oct 2020 //
BUSINESSWIRE
Prestige Biopharma Receives +ve EMA Opinion on Orphan Designation for PBP1510
19 Oct 2020 //
BUSINESSWIRE
Prestige Receives Positive EMA Opinion on Orphan Designation for PBP1510
12 Oct 2020 //
B3NEWSWIRE
Alvotech, Prestige Biopharma Enter New Manufacturing Partnership
28 Aug 2019 //
CONTRACT PHARMA
Mundipharma picks up rights to Herceptin biosimilar Tuznue
02 Jul 2019 //
PHARMATIMES
